MTS

Cremieux joins MTS to discuss China's rapid ascent to the top of global clinical trial output, the structural regulatory reforms that drove it, and what the US would need to do to close the gap. He covers novel gene therapy pipelines, the market authorization holder system, and why pharmaceutical profit margins may be the biggest bottleneck to American biomedical innovation. -- MTS is a live n...

Aella joins MTS to discuss AI doom, transhumanism, and the economic illiteracy of young people. She walks through her approach to microdosing psychedelics, her views on wireheading and gene editing, and her new creator project Please Don't Kill Us. -- MTS is a live news and interview show covering technology, business, politics, and culture as it happens. Follow MTS: X | ⁠⁠⁠⁠⁠https://twitter.c...

Balaji Srinivasan joins Erik Torenberg and Theo Jaffee on MTS to discuss why media sits upstream of politics and money, how tech can build verifiable alternatives to legacy news, and what polytheistic AI and on chain proof mean for the next decade. https://x.com/balajis -- MTS is a live news and interview show covering technology, business, politics, and culture as it happens. Follow MTS: X | ⁠⁠⁠⁠...

Marc Andreessen joins MTS to discuss why the shape of media determines behavior, how CNN's original "it" strategy became today's current thing cycle, and why moral panics, availability cascades, and scapegoating keep repeating across new and legacy outlets. -- MTS is a live news and interview show covering technology, business, politics, and culture as it happens. Follow MTS: X |...

Coming soon.